OPs (organophosphylates) exert their acute toxicity through inhibition of acetylcholinesterase, by phosphylation of the catalytic serine residue. Engineering of human butyrylcholinesterase, by substitution of a histidine residue for the glycine residue at position 117, led to the creation of OP hydrolase activity. However, the lack of structural information and poor understanding of the hydrolytic mechanism of the G117H mutant has hampered further improvements in the catalytic activity. We have solved the crystallographic structure of the G117H mutant with a variety of ligands in its active site. A sulfate anion bound to the active site suggested the positioning for an OP prior to phosphylation. A fluoride anion was found in the active site when NaF was added to the crystallization buffer. In the fluoride complex, the imidazole ring from the His 117 residue was substantially shifted, adopting a relaxed conformation probably close to that of the unliganded mutant enzyme. Additional X-ray structures were obtained from the transient covalent adducts formed upon reaction of the G117H mutant with the OPs echothiophate and VX [ethyl ({2-[bis-(propan-2-yl)amino]ethyl}sulfanyl](methyl)phosphinate]. The position of the His 117 residue shifted in response to the introduction of these adducts, overlaying the phosphylserine residue. These structural data suggest that the dephosphylation mechanism involves either a substantial conformational change of the His 117 residue or an adjacent nucleophilic substitution by water.
INTRODUCTION
Recent progress in the understanding of enzyme catalysis, through the use of structural biology and molecular modelling, has opened a new era in protein engineering. It is now possible to develop rational strategies for modifying enzymes to confer upon them the ability to catalyse reactions for which they were not originally designed [1] . Human butyrylcholinesterase (BChE; EC 3.1.1.8) is an enzyme for which modifying its catalytic activity has been an ongoing subject of interest. This enzyme is related to acetylcholinesterase (AChE; EC 3.1.1.7), the enzyme that terminates the action of the neurotransmitter acetylcholine at postsynaptic membranes and neuromuscular junctions. BChE differs from AChE by its substrate specificity and inhibitor sensitivity [2, 3] . Although BChE is present in numerous vertebrate tissues, its physiological role remains unclear [4] .
Considerable interest has been shown in BChE because it hydrolyses a wide range of toxic esters, including heroin and cocaine, and because it scavenges toxic OP (organophosphylate) pesticides and nerve agents [5−7] . A lot of effort has been expended to improve its ability to hydrolyse these compounds. Redesign of its active site has improved its cocaine hydrolase activity 2000-fold, turning it into a very efficient cocaine detoxifying tool [8] . This redesign was based on hybrid QM/MM (quantum mechanical/molecular mechanical) studies aimed at finding ways to stabilize the acylation transition state of the cocaine hydrolysis reaction.
Reaction of cholinesterases with OP compounds is another area in which modification of the native cholinesterase activity has received considerable attention. This is a consequence of the irreversible inhibition of AChE (at the neuronal synapses and neuromuscular junctions) by OP compounds which leads to accumulation of acetylcholine and results in paralysis, seizures and other symptoms of cholinergic syndrome. Under extreme conditions, inhibition of AChE can lead to death [9] . Native plasma BChE works well as a stoichiometric bioscavenger because it reacts very efficiently with OP compounds, trapping them in a 1:1 complex in the bloodstream before they can reach synaptic AChE. Injection of wild-type BChE, intravenously or intramuscularly, protects animals against three to five LD 50 of the nerve agents soman [2-(fluoromethylphosphoryl)oxy-3,3-dimethylbutane], VX [ethyl ({2-[bis(propan-2-yl)amino]ethyl}-sulfanyl)(methyl)phosphinate] and tabun ethyl (N,Ndimethylphosphoramidocyanidate) [10] . BChE purified from human plasma (Baxter Healthcare) or produced in the milk of transgenic goats [11] has successfully completed clinical trials and is about to reach the market as a bioscavenger for pre-treatment against OP intoxication. A BChE dose up to 250 mg/70 kg of body weight is required to achieve efficient protection of humans following a challenge with one LD 50 Abbreviations used: AChE, acetylcholinesterase; BChE, butyrylcholinesterase; CHO, Chinese-hamster ovary; DEP, diethoxyphosphoryl; OP, organophosphylate; QM/MM, quantum mechanical/molecular mechanical; RMSD, root mean square deviation; TLS, translation libration screwmotion '. 1 To whom correspondence should be addressed (email florian@nachon.net).
of OPs [12] . Thus a large amount of enzyme is necessary to achieve an efficient protection. This is due to the stoichiometric and irreversible nature of the reaction between the OP and BChE, and to the unfavourable OP/BChE mass ratio. Such large doses are expensive, and will prevent the widespread use of wild-type BChE as a pre-treatment. Research efforts are now devoted to circumventing this limitation by developing catalytic bioscavengers able to hydrolyse OPs [13] . Very early in the study of OP inhibition of cholinesterases, it was suggested that OP inhibitors could be considered as hemisubstrates of cholinesterases because formation of the enzyme−inhibitor complex was efficient but the dephosphylation was not. Slow dephosphylation was presumed to be a consequence of there being no amino acid groups at the appropriate positions to catalyse hydrolysis by in-line nucleophilic attack of water [14] . The idea of introducing a residue that was capable of catalysing the dephosphylation step into the active site came after. In principle, after such a modification, OPs would become full substrates for the modified cholinesterase, or, in other words, the added residue would turn the cholinesterase into an OP-hydrolase, i.e. a catalytic bioscavenger [15] .
This approach proved to be qualitatively successful. BChE was shown to gain OP hydrolase activity when a histidine residue was substituted for the glycine residue at position 117 [16, 17] . The G117H mutant is remarkably efficient at hydrolysing echothiophate, having a catalytic rate constant, k cat of 0.75 min − 1 in 0.1 M potassium phosphate, pH 7.0, at 25
• C. The G117H mutant can also hydrolyse the nerve agents sarin, VX and, additionally, soman if a second mutation (E197Q) is introduced to prevent fast aging of the conjugate [18] . Dephosphylation remains the rate-limiting step with k cat of 5.2 × 10 − 3 min − 1 for sarin, 7.2 × 10 − 3 min − 1 for VX and 77.0 × 10 − 3 min − 1 for the most toxic isomer of soman (P S C S ) (0.067 M phosphate buffer, pH 7.5, at 25
• C). Furthermore, it has been shown that transgenic mice expressing the G117H mutant are resistant to OP [19] . Although the G117H/E197Q mutant is generally considered to reactivate too slowly to be of general use as a catalytic bioscavenger for nerve agents, it provides an improvement over the native enzyme. Spontaneous reactivation of soman-, sarinor VX-inhibited G117H/E197Q replenishes half of the affected enzyme in approx. 10 min [18] . This could be lifesaving in a scenario where successive exposures to these OPs occur.
To date, more than 60 BChE mutants have been made in an effort to improve the OP hydrolase activity of the original G117H mutant. It was found that G117D, G117E, L286H and several G117H-based double and triple mutants were capable of hydrolysing echothiophate [20] . However, the G117H mutant remains the most efficient by at least two orders of magnitude. One reason for this relative failure to find an improved mutant is that the dephosphylation mechanism is poorly understood. Knowledge of the structure of the active site of the G117H mutant now appears to be critical in order to understand the catalytic mechanism and to design more efficient G117H-based mutants. An indication of the pressing need for an experimentally determined structure of the active site of the G117H mutant is provided by two recent publications [21, 22] in which the threedimensional structure of the G117H BChE mutant was determined computationally. Although they are interesting, such models cannot replace an experimental structure.
In the present paper we provide the X-ray structure of the G117H mutant, the structures of the transient covalent adducts formed upon reaction of the G117H mutant with echothiophate and VX (Figure 1) , and the structure of a fluoride complex that was the consequence of an attempt to create a transitionstate phosphate analogue in the form of MgF 3
− . These crystal The asterisk (*) denotes a chiral centre.
structures give a true picture of the active site of the G117H mutant under a variety of conditions and provide the essential information needed to perform QM/MM studies aimed at designing mutants with improved hydrolytic capabilities. The crystallizable low-glycosylated monomeric form of human BChE was mutated into the G117H [16] , produced in CHO (Chinese-hamster ovary) cells and purified under conditions similar to those described for the wild-type enzyme [23] . Crystals of the G117H mutant were prepared in five ways. First, crystals of the G117H mutant were grown in an ammonium sulfate containing mother liquor as previously reported, using the hanging-drop vapour-diffusion method, at room temperature [23] . Secondly, crystals were grown in the mother liquor plus 5 mM MgCl 2 and 10 mM NaF as additives. The purpose of this crystallization condition was to generate crystals wherein MgF 3 − would appear as a mimic for PO 3 − in the active site of the G117H mutant. Thirdly, crystals were grown in the presence of 5 mM Al(NO 3 ) 3 − and 10 mM NaF with the purpose of generating crystals with AlF 4 − in the active site, again as a mimic for PO 3 − . Fourthly and fifthly, crystals of the VX−G117H and echothiophate−G117H phosphylated enzyme transient adducts were prepared by flash-soaking the G117H mutant crystals for 2 min in 0.1 M Mes buffer, pH 6.5, 6 % glycerol and 2.1 M ammonium sulfate containing either 1 mM VX or 1 mM echothiophate. The crystals were then washed with a cryoprotectant solution (0.1 M Mes buffer, pH 6.5, with 2.1 M ammonium sulfate, containing 20 % glycerol) and flash-cooled in liquid nitrogen. At this stage, the VX-adduct in the crystals of VX-G117H BChE presents absolutely no danger.
EXPERIMENTAL

X-ray data collection and structure solution
Diffraction data for the G117H mutant (i) without additives, (ii) with MgCl 2 and NaF, (iii) with Al(NO 3 ) 3 − and NaF, or (iv) after formation of the echothiophate−G117H adduct were collected at the European Synchrotron Radiation Facility (ESRF, Grenoble, France), on the ID14-2 beamline using a wavelength of 0.933 Å (1 Å = 0.1 nm) and an ADSC Quantum 4 detector. Diffraction data for the VX−G117H adduct were collected at the ESRF on the ID23-2 beamline using a wavelength of 0.873 Å and a MAR-Research charge-coupled detector. All datasets were processed with XDS (http://xds.mpimf-heidelberg.mpg.de/) [24] . The structures were solved using the CCP4 suite (http://www.ccp4.ac.uk/) [25] . An initial model was determined by molecular replacement with MolRep [26] , starting with the recombinant BChE structure (PDB code 1P0I) from which all ligands and glycan chains were removed. For all diffraction datasets, the model was refined as follows. An initial rigidbody refinement was made with REFMAC5 [27] , which was followed by iterative cycles of model building with Coot [28] . Finally, restrained and TLS (translation libration screwmotion) refinements were carried out with REFMAC5. The bound ligands and their descriptions were built using the Dundee PRODRG2.5 server (http://davapc1.bioch.dundee.ac.uk/prodrg/), including energy minimization using GROMOS96.1 force field. Significant falls in R-factor and R-free occurred during the TLS refinement. TLS groups were defined with the help of the TLS Motion Determination server (http://skuld.bmsc.washington.edu/∼tlsmd/index.html) [29] . The refined TLS parameters are included in the deposited PDB file for each entry. SA-composite omit maps were calculated using Phenix (http://www.phenix-online.org/) [30] in order to check for any bias in the model. Protein structures were displayed using the program PyMOL (DeLano Scientific; http://www.pymol.org).
RESULTS
Crystallographic structure of the G117H mutant without additives
Crystals were grown in the absence of any extra additives, using ammonium sulfate as a precipitant. Data were collected from tetragonal crystals of space group I422 and refined to 2.1 Å. The space group is identical with that formed by the wild-type enzyme. Data and refinement statistics are summarized in Table 1 . The mutation does not induce any noticeable conformational change in the enzyme as shown by the marginal all-atoms RMSD (root mean square deviation) of 0.205 Å between G117H BChE and the wild-type BChE (PDB code 1P0I). In particular, the mainchain atoms of the Gly 117 residue in the wild-type enzyme and the His 117 residue in the mutant enzyme superimpose very well (RMSD = 0.225 Å).
Unexpectedly, there is a sulfate ion bound in the active site, opportunely mimicking an OP about to be attacked by the catalytic serine residue (Figure 2A ). The sulfur atom of the sulfate ion is 2.8 Å from Ser 198 −Oγ ; the O1 and S atoms of SO 4 2 − and the Ser 198 −Oγ atom are colinear (175 • ); the distance between the O1 and Ser 198 −Oγ atoms is 4.3 Å which favourably compares with the distance between the oxygens located at the apical vertices of a trigonal-bipyramidal phosphorus transition state (4.1 Å). However, the 2F o -F c map does not reveal any continuity of electron density between the S and Ser 198 −Oγ atoms. Such continuity would have suggested a covalent bond between these atoms. The O4 atom of the SO 4 2 − is well stabilized in the oxyanion hole, being at hydrogen-bonding distance from the main-chain nitrogens of the could indicate the conformation in the OP complex just prior to phosphorylation of the Ser 198 residue. As is often observed in the crystal structures of wild-type BChE [32−35] , there is an unidentified ligand stacked against Trp 82 that we chose to model with dummy atoms. This ligand is at hydrogenbonding distance from the O2 atom of SO 4 2 − (2.9 Å). In addition, the O1 atom is at hydrogen-bonding distance (2.5−3.0 Å) from another unidentified ligand, the electron density of which stretches between the Gln 119 , His 117 and Thr 120 residues. This density was also modelled by dummy atoms.
Crystallographic structure of the G117H mutant in complex with fluoride
Data were collected from tetragonal crystals grown in the presence of MgCl 2 and NaF. The original rationale for using these additives was to trap a transition-state analogue in which MgF 3 − would mimic PO 3 − [36] . This structure was refined to 2.4 Å resolution (see the details in Table 1 ).
There are two peaks of electron density in the F o -F c omit maps (green mesh, 4.5 σ ). Both are present at the heart of a dense hydrogen-bond network involving the oxyanion hole, the catalytic serine residue (Ser 198 ) and the catalytic histidine residue (His 438 ) ( Figure 2B ). One peak probably corresponds to a water molecule which forms one edge of a triangular hydrogen-bond network involving the Ser 198 −Oγ and His 438 −Nε2 atoms. The second peak corresponds to an atom that strongly interacts with both the water molecule (2.6 Å) and the Ser 198 −Oγ (2.5 Å) atom, and is at hydrogen-bonding distance from the three main-chain nitrogens of the oxyanion hole residues (Gly 116 , 3.0 Å; His 117 , 2.8 Å; and Ala 199 , 2.9 Å). As the molecule represented by this density was able to displace the sulfate ion that was observed in the absence of NaF, and because there is a three-pronged interaction with the oxyanion hole as expected for a fluoride anion, we modelled this density as a putative fluoride ion. This interpretation is supported by the fact that the fluoride anion is known to be a reversible inhibitor of BChE [37−39] . Although binding sites have not been identified yet, it has been reported that fluoride competes with OPs and it has been proposed that the binding involves two or more hydrogen donors necessary for enzyme catalysis [40] . Alternatively, a water molecule has been observed in a position similar to that of this putative fluoride ion for some BChE structures [41] . However, the interaction of that water with the oxyanion hole was clearly weaker, based on the distance of hydrogen donors, suggesting a two-pronged hydrogenbond interaction.
Although the general conformation of the His 117 residue in this structure is well resolved, the orientation of the imidazole ring is not. This is because there are two peaks of electron density in the F o -F c maps, one on each side of the imidazole ring, suggesting alternative interactions of the His 117 −Nδ1 atom with two water molecules at relatively low occupancy. In the first option, the c1 and c2 angles of the His 117 residue are − 48
• and 103
• respectively (this is the structure shown in Figure 1B ). The water molecule (peak at 4.1 σ ) is at hydrogen-bonding distance from the backbone nitrogen of the Thr 120 residue (3.1 Å), and interacts strongly with the His 117 −Nδ1 atom (2.5 Å). In the alternative refined model (position not shown in Figure 2B ), the ring is simply flipped with c1 = − 46
• and c2 = − 71
• . The water molecule (peak at 3.5 σ ) is at hydrogen-bonding distance from the carbonyl oxygen of the Leu 286 residue (3.1 Å), and interacts very strongly with the His 117 −Nδ1 atom (2.4 Å). This conformation is reasonably close to the m − 70
• histidine conformation from the penultimate rotamer library (c1 = − 65
• and c2 = − 70 • ) [31] . We favoured the first option for the final model of the His 117 residue because it better modelled the strongest peak in the F o -F c map and because it kept both water molecules in the structure. The conformation of the His 117 residue adopted in Figure 2 (B) is probably representative of that found in the mutant structure in the absence of ligands.
Following the same logic we used for MgCl 2 and NaF as additives, we grew crystals in the presence of 5 mM Al(NO 3 ) 3 and 10 mM NaF. The idea was to trap an AlF 4 − -based transition-state analogue of PO 3 − in the active site [42] . The crystal structure was refined to 2.4 Å resolution (results not shown). It yielded a crystal structure that was identical with that found when the crystals were grown in the presence of MgCl 2 and NaF. This confirmed that fluoride was the key additive leading to the observed complex.
Crystallographic structure of echothiophate−G117H transient adduct
Data were collected from a crystal that was flash-soaked for 2 min in a solution containing 1 mM echothiophate. We chose to prepare the crystal in this way because dephosphorylation is partly rate-limiting for the hydrolysis of echothiophate (1.2 min − 1 ) [17] . Therefore we assumed that the phosphoryl intermediate would likely accumulate in the crystal in the presence of excess echothiophate. The structure was refined to 2.3 Å (see details in Table 1) .
A strong peak of positive electronic density (11.8 σ ), within covalent-bonding distance of the catalytic serine residue was seen in the initial F o -F c map ( Figure 1C ). This is consistent with the presence of a bound DEP (diethoxyphosphoryl) moiety. The position of the DEP is similar to that which it adopts in wild-type BChE (PDB code 1XLW) [33] . The phosphorus atom is found at a covalent-bonding distance of 1.64 Å from the Ser 198 −Oγ atom. The O3 atom, the phosphoryl oxygen, is at hydrogen-bonding distance from the main-chain amide nitrogens of the oxyanion hole residues with the shortest distance 7 Å) . As a consequence, the distance between DEP−C3 and water molecule 2113 is only 2.9 Å in the DEP−G117H mutant compared with 3.8 Å in wild-type DEP−BChE. Thus the imidazole of the His 117 residue appears to be an obstacle to the formation of the phosphylated enzyme.
Given the preeminent role of water molecule 2113 in the dealkylation of DEP, it is expected that a shorter distance between DEP−C3 and water molecule 2113 would be more favourable for the aging reaction. This was experimentally verified. The dealkylation rate of the DEP−G117H mutant is about seven times higher than that for wild-type DEP−BChE under similar conditions [17] .
The His 117 residue also induces a slight rearrangement of the second ethoxy group of DEP and its environment. The imidazole ring prevents DEP−C2 from pointing toward the Val 288 residue, and thus DEP-C2 is forced toward the Leu 286 residue. In response, the Leu 286 −Cδ1 and Leu 286 −Cδ2 atoms shift away by approx. 1 Å. A similar rearrangement of the Leu 286 residue was observed previously in an N-diethylphosphoramidyl conjugate of BChE [35] .
The His 117 residue adopts a stable conformation (c1 = − 62 • ; c2 = − 76
• ) corresponding to m − 70
• from the penultimate rotamer library. The imidazole ring is lying flat, above the DEP. This conformation is stabilized by a hydrogen bond between the His 117 −Nε2 and the Pro 285 −carbonyl−O atoms, and a hydrogen bond to a water molecule bridging the His 117 −Nδ1, and Thr 120 −Oγ 1 atoms. The distances between the His 117 residue and the phosphorus of DEP provide some basis on which to address the mechanism of dephosphorylation for DEP−G117H. The His 117 −Nδ1 atom is 4.6 Å from DEP−P and 3.9 Å from DEP−C3 (1.3 and 0.6 Å channel width respectively). These distances are too short to allow a water molecule to fit between the His 117 residue and the phosphorus as depicted on Scheme 1 (pathway B, 'attack is anti'). For this path to be active, a conformation change of the His 117 residue would have to occur. Alternatively, because the His 117 −Nδ1, DEP−P and Ser 198 −Oγ atoms are almost colinear (168 • ), a simple rotation of the imidazole ring by − 60 • around the Cβ−Cγ atoms would place the Nδ1 atom of the His 117 residue 3.7 Å from DEP−P with the nitrogen lone pair pointing toward the phosphorus atom. This situation seems plausible for a nucleophilic attack of the His 117 residue on the phosphorus, i.e. the 'Nucleophile is His 117 ' path as depicted in Scheme 1 (pathway A).
Crystallographic structure of VX−G117H transient adduct
Data were collected from a crystal that was flash-soaked for 2 min in a solution containing 1 mM VX. The reasons for preparing
Scheme 1 Potential mechanisms for the hydrolysis of echothiophate by the G117H mutant
The upper pathway (A) involves the nucleophilic attack by the His 117 residue on the phosphorus of the adduct followed by the hydrolysis of the phosphylhistidine by a water molecule. The lower pathways involve a nucleophilic attack by a water molecule on the phosphorus of the adduct, either from a position anti (B) or adjacent (C and D) to the catalytic serine residue.
the crystal in this way are the same as those described in the 'Crystallographic structure of echothiophate−G117H transient adduct' section. As the dephosphonylation rate of VX−G117H is 200-fold lower than that of diethylphosphoryl−G117H, trapping the hydrolysis intermediate was expected to be less challenging. The structure was refined to 2.7 Å (see details in Table 1) .
No water molecule equivalent to 2113 is present in the active site of the VX−adduct structure ( Figure 2D) . A peak of electron density more than 4 Å away from the His 438 and Glu 197 residues was modelled as an ammonium ion likely to be electrostatically interacting with the Glu 197 residue and the π system of the Trp 82 residue (results not shown).
A peak in the initial F o -F c map (3.7 σ ) was found at a covalentbonding distance from the Ser 198 −Oγ atom (1.7 Å). The absolute configuration of the phosphorus atom is P(S). The methyl group is pointing towards the His 438 residue ( Figure 2D ). The ethoxy group is located in the acyl-binding pocket defined by the Leu 286 , Val 288 and Trp 231 residues. This orientation is the mirror image of that observed in VX−TcAChE [44] , but identical with that observed in VX−BChE (results not shown).
The ethoxy group points towards the Val 288 residue and superimposes very well on the equivalent ethoxy in the wildtype DEP−BChE structure. However, this orientation is different from that just described for the DEP−G117H structure where the ethoxy group was pointing towards the Leu 286 residue. As a consequence, the shift of the Leu 286 residue that is observed in the DEP−G117H conjugate does not occur in the VX−G117H conjugate. Also, the carbonyl oxygen from the Pro 285 residue is not available for interaction with the His 117 −Nε2 atom. This is reflected in two conformations for the His 117 residue that differ by the ring orientation, c1 = − 7
• and c2 = − 124 • or c1 = − 7
• and c2 = 57
• . These conformations are far from common histidine rotamers. This unusual conformational arrangement may be a consequence of the asymmetry of the adduct. That is, the His 117 residue imidazole ring is shifted over the methyl substituent and away from the bulkier ethoxy. In this position, it cannot be stabilized by hydrogen-bonding because it is too far from the acceptors in the acyl-binding pocket, and too close to the Thr the His 117 residue in the VX−G117H adduct do not permit the orientation of the imidazole ring to be determined with confidence.
Much like in the DEP−G117H structure, the His 117 −Nδ1 atom is at 4.5 Å from DEP−P and 3.8 Å from DEP−C3. These short distances would not allow a water molecule to get between the phosphorus and the His 117 residue in the absence of a large conformational change. The His 117 −Nδ1, DEP−P and Ser 198 −Oγ atoms are less colinear (157 • ) than in the DEP−G117H conjugate. Cβ for the His 117 residue in the VX−G117H adduct is offset by 0.7 Å from its position in DEP−G117H adduct (Figure 3 ). Thus the maximum allowable side-chain rotation around Cβ−Cγ is − 50
• . That would partially orient the lone electron pair of the His 117 −Nδ1 atom towards the adduct, but any further motion towards the phosphorus atom would lead to a clash between the His 117 −Nδ1/Cε2 atoms and the methyl substituent of the VX. This situation is less favourable for a nucleophilic attack of the His 117 residue on the phosphorus than was the case in the DEP−G117H intermediate.
DISCUSSION
Impact of mutations at position 117 on the activity of BChE and related enzymes
When BChE is mutated at position 117 it loses catalytic efficiency for the hydrolysis of thio-and oxo-esters [15, 16] . It was hypothesized that this loss in activity was related to a change in the orientation of the His 117 residue nitrogen proton donor of the oxyanion hole, leading to weaker transition state stabilization owing to suboptimal hydrogen-bonding [45] . We observe no such change in the X-ray structures of G117H presented in the present paper (Figure 3) . Although there is some heterogeneity in the positions adopted by His 117 , depending on the adduct, the positions of the critical oxyanion hole residues are unchanged.
Alternatively, loss of activity towards the normal thio-oxoesters may be due to the imidazole ring of the His 117 residue blocking the approach of substrate and water. This suggestion is based on the fluoride-G117H structure, which we take to be representative of the unliganded resting enzyme. In this structure, the His 117 residue clutters access to the oxyanion hole ( Figure 3B ), and is very likely to be a steric obstruction to the formation of all substrate complexes, including the transition state. A change in the position of the His 117 residue would be necessary in order to properly orient a substrate in the oxyanion hole, but even then optimal orientation may not be achieved.
Such a conformational change is seen in the sulfate complex. If the His 117 residue were to maintain the position observed in the fluoride complex, it would collide with the sulfate oxygen that is opposite the serine. Consequently, the histidine residue is forced sideways in the sulfate complex.
Similarly, proper fitting of an OP into the active site of BChE requires a conformational change of the His 117 residue (compare Figure 2A with Figures 2C and 2D) . Such steric hindrance from the His 117 residue could explain the two-to-four-orders of magnitude decrease in phosphylation rates observed for OPs reacting with G117H [46] .
Loss of sensitivity to OP inhibitors in insects may be attributed to the same phenomenon. For example, a natural mutation in mosquito acetylcholinesterase G119S, a position equivalent of Gly 117 in BChE, is at the origin of their resistance to OP pesticides [47] . No OP-hydrolase activity was reported for this mutant, but resistance could arise from decreased affinity for OP. It is noteworthy of mention that no OP-hydrolase activity was observed for the equivalent BChE mutant, G117S [20] . A second example is the G137D mutant of carboxylesterase from sheep blowfly [48] . Position 137 is equivalent to position 117 in BChE and substitution an aspartate residue for the glycine residue at this position would be expected to hinder access to the oxyanion hole. The G137D mutation reduces sensitivity to OPs and confers OPhydrolase activity on the carboxylesterase. OP-hydrolase activity was also found for the equivalent G117D mutation in BChE [20] . Finally, a triple mutation in Bungarus fasciatus AChE aimed at introducing a histidine into a position homologous with position 117 of BChE reduces sensitivity to OPs and turns this enzyme into an OP hydrolase [49] .
Candidate mechanisms for catalytic dephosphylation
Four different mechanisms have been proposed by previous investigators to explain why dephosphylation of G117H BChE is faster than dephosphylation of the native enzyme (Scheme 1).
Mechanism A
The first mechanism is based on a nucleophilic attack of the His 117 residue on the phosphorus, leading to a phosphylhistidine intermediate that is subsequently hydrolysed (Scheme 1, pathway A, the 'Nucleophile is His 117 '). This mechanism was originally proposed by Fortier and colleagues on the basis of molecular mechanics calculations [50] .
One argument against this mechanism is that phosphohistidines have a high-energy phosphoramidate bond and tend to transfer the phosphoryl group to other molecules [51, 52] . Thus it would be expected that a phosphylhistidine would transfer its phosphyl moiety to the serine residue and not the other way around. Following this reasoning, early investigators proposed that the OP-serine adduct was formed via an intermediate OP-histidine donor rather than through a direct phosphylation by the OP [53] .
Support for nucleophilic attack by the His 117 residue on the phosphorus comes from the colinearity of the His 117 −Nδ1, the phosphorus and Ser 198 −Oγ atoms in the DEP−G117H conjugate, and to a lesser extent in the VX−G117H conjugate. A 60
• rotation of the imidazole ring around the Cβ−Cγ bond would orient the lone pair of electrons on the nitrogen toward the phosphorus for direct nucleophilic attack. Unfortunately, the phosphorus substituents are in close contact with the imidazole ring and these interactions would prevent a simple rotation around Cβ−Cγ bond. Rotation could occur only if the His 117 residue moved back from the phosphorus substantially. Even if the simple rotation were to occur, the imidazole would still be 3.7 Å from the phosphorus, too far for covalent interaction. Taken together, the crystal data and the thermodynamics argue that pathway A is unlikely. Proof for this mechanism would require trapping of the phosphylhistidine intermediate.
Mechanism B
The second mechanism is a nucleophilic attack by water on the phosphorus atom, promoted by the His 117 residue. The oxygen of the attacking water would have to be positioned opposite the serine-phosphorus bond, i.e. in an apical or 'anti' position (Scheme 1, pathway B, 'attack is anti'). This mechanism formed the basis of the original rationale for the design of the G117H mutant [54] . Broomfield et al. [54] reasoned that "it might be possible to introduce a second nucleophilic centre into the active site in such a position that it could carry an activated water molecule to the face of the phosphorus moiety opposite the phosphorus-serine bond and thereby reactivate the enzyme". Newcomb et al. [48] extended this mechanism to the G137D mutant of the sheep blowfly carboxylesterase, the aspartate residue acting as a base to orient a water molecule in the appropriate position for hydrolysis. By analogy, this mechanism was also proposed for the G117D, G117E and L286H BChE mutants [20] . Finally, this mechanism was recently re-proposed by Amitay and Shurki [21] and His 438 residues of BChE. The His 12 residue serves as a base to abstract a proton from the 2 -oxygen of the RNA substrate molecule, thereby activating it for attack on the phosphorus. The His 119 residue serves as an acid to protonate the oxygen of the leaving group [55] .
The X-ray structures in Figures 2(C) and 2(D) show that the imidazole of the His 117 residue is in close contact with the phosphorus. In this position, the His 117 residue would not allow a water molecule to approach the phosphorus. A large conformational change of the His 117 residue would be required to make room. In addition, if one considers the sulfate−G117H complex to be a structural analogue of the dephosphylation transition state for mechanism B, then the formation of the transition state is obstructed by the ethoxy moiety in the acyl-binding pocket as seen by the superimposition of the sulfate, VX and DEP−G117H (Figure 3) . Finally, the imidazole of the His 117 residue is an obstacle to the formation of the dephosphylation transition state, much like it is an obstacle to the formation of the phosphylation transition state in agreement with kinetic data [16] . These observations argue that a conformational change in the active centre would be necessary for mechanism B to occur. A partially rate-limiting conformational change in the course of forming the transition state for dephosphylation is consistent with the weak pH dependencies observed for dephosphylation [16, 17] . QM/MM calculations based on the structures herein would be needed in order to determine if the change of conformation required corresponds to an energy barrier compatible with the measured dephosphylation rate.
Mechanism C
The third mechanism, which was proposed by Millard et al. [16] , derives from the suggestion of Kovach [56] 438 residue free to form a hydrogen bond with a water molecule. Abstraction of a proton from that water molecule would promote attack of the water on the phosphorus atom. The structure of the VX−G117H adduct ( Figure 2D ) shows no hydrogen-bonding interactions for the imidazole of the His 117 residue with the ethoxy substituents. The structure of DEP−G117H ( Figure 2C) shows the His 117 residue making hydrogen-bond contact with water molecules but not with the ethoxy substituent. In the DEP−G117H complex the His 438 residue is at an optimal position to transfer a proton between a water molecule and the serine residue while maintaining a hydrogen bond to an ethoxy group. These observations refute the idea that hydrogen-bonding of the His 438 residue to an ethoxy group is a critical feature of phosphylated G117H that would prevent it from acting as a base catalyst.
Mechanism D
The structure in Figure 2 (C) supports a mechanism in which a water molecule could be activated by the His 438 residue for attack on the phosphorus atom. The His 438 residue in DEP−G117H is hydrogen-bonded to a water located near the wide-open face of the DEP adduct, adjacent to the Ser 198 residue (Scheme 1, pathway C). If the His 438 residue is deprotonated then it could abstract a proton from the entering water molecule and subsequently transfer it to the serine. Alternatively, if it is protonated then it could serve as a relay in a concerted proton transfer from the water molecule to the catalytic serine residue as depicted in Scheme 1, pathway C. A similar adjacent nucleophilic substitution mechanism has been proposed in some phosphylation and aging reactions of cholinesterases [57, 58] .
Hydrogen-bonding of the water to the Glu 197 residue that is seen in Figure 2 (C) can further stabilize the approaching water molecule. A role for the Glu 197 residue in dephosphylation is supported by the observation that there is 40-fold decrease in the dephosphorylation rate of the echothiophate−G117H/E197Q mutant [20] , but a 10-fold increase in the dephosphonylation rate for VX-and sarin-G117H/E197Q mutants [18] .
In mechanism D, the His 117 residue could accelerate dephosphylation by destabilizing the transient phosphylserine by steric obstruction. Indeed, the conformation of the His 117 residue in the DEP− and methylethoxyphosphonyl−G117H transient conjugates, appears to be strained by comparison with the relaxed conformation observed in the fluoride−G117H complex (Figure 3) . The imidazole ring puts a lot of strain on the phosphyl moiety and can be viewed as a molecular analogue of a loaded spring. This should result in a high-energy structure, destabilizing the adduct. The destabilizing role of the His 117 residue in the transition state would therefore be simply steric exclusion. Given this thesis, a diethylphosphoryl adduct is expected to be under greater strain than a methylethoxyphosphonyl adduct, thus explaining the higher hydrolysis rate for echothiophate than for VX. Additionally, if the His 117 residue is charged, it is expected to enhance the electrophily of the phosphorus atom by a local electrostatic effect. These effects would also be consistent with the modest pH dependence on the dephosphylation step [16, 17] . All things considered, mechanism D appears to be most consistent with the X-ray data.
In summary, the structures reported in the present paper are not sufficient to definitively identify the molecular mechanism of G117H phosphyl hydrolysis; however, they do provide a basis on which to question the currently advanced possibilities. In addition, the X-ray structures of the echothiophate−G117H and VX−G117H adducts provide indispensable structural templates for future QM/MM calculations and valuable structural starting points for further explorations into the hydrolysis mechanism. The proposals provided in this discussion also may provide guidance for computational mutagenesis directed at improving the dephosphylation rates for the G117H mutant. A mutagenesis strategy based on computational design was successfully implemented to create a mutant of BChE with improved cocaine hydrolase activity [59] . Such a strategy could be applied to the design of new cholinesterases or other serine hydrolase mutants that can more efficiently reactivate from OP inhibition. Efficient catalytic bioscavengers would provide a great improvement in prophylaxis, decontamination and treatment of organophosphylate poisoning.
AUTHOR CONTRIBUTION
Oksana Lockridge produced and purified the mutant enzyme. Florian Nachon, Eugenie Carletti and Marielle Wandhammer made the crystals, and collected and processed the diffraction data. Yvain Nicolet participated in the diffraction data collection. Florian Nachon analysed the structures. Patrick Masson, Lawrence Schopfer and Florian Nachon wrote the manuscript. Oksana Lockridge and Florian Nachon designed and planned the project.
